Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

<p><strong> Background</strong></p> Dexamethasone and remdesivir have the potential to reduce coronavirus disease 2019 (COVID)–related mortality or recovery time, but their cost-effectiveness in countries with limited intensive care resources is unknown. <p><strong&...

Полное описание

Библиографические подробности
Главные авторы:	Jo, Y, Jamieson, L, Edoka, I, Long, L, Silal, S, Pulliam, JRC, Moultrie, H, Sanne, I, Meyer-Rath, G, Nichols, BE
Формат:	Journal article
Язык:	English
Опубликовано:	Oxford University Press 2021

Схожие документы

The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing intensive care unit capacity
по: Nichols, BE, и др.
Опубликовано: (2020)

The National COVID-19 Epi Model (NCEM): estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa
по: Silal, SP, и др.
Опубликовано: (2023)

The role of modelling and analytics in South African COVID-19 planning and budgeting
по: Meyer-Rath, G, и др.
Опубликовано: (2023)

Differential in-hospital mortality and intensive care treatment over time: informing hospital pathways for modelling COVID-19 in South Africa
по: Jamieson, L, и др.
Опубликовано: (2023)

Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System
по: Ijeoma Edoka, и др.
Опубликовано: (2022-08-01)

Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa.
по: Lise Jamieson, и др.
Опубликовано: (2023-01-01)

The role of modelling and analytics in South African COVID-19 planning and budgeting.
по: Gesine Meyer-Rath, и др.
Опубликовано: (2023-01-01)

The role of modelling and analytics in South African COVID-19 planning and budgeting
по: Gesine Meyer-Rath, и др.
Опубликовано: (2023-01-01)

The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa
по: Sheetal Prakash Silal, и др.
Опубликовано: (2023-01-01)

The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa.
по: Sheetal Prakash Silal, и др.
Опубликовано: (2023-01-01)

Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa
по: Silal, SP, и др.
Опубликовано: (2022)

Dexamethasone and remdesivir: finding method in the COVID-19 madness
по: Pauline Vetter, и др.
Опубликовано: (2020-12-01)

Cancer mortality trends in South Africa: 1997 - 2016
по: M L Nhleko, и др.
Опубликовано: (2023-08-01)

A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
по: Dallis Q. Ngo, и др.
Опубликовано: (2022-01-01)

Pancreatic cancer mortality in South Africa: A case-control study
по: M L Nhleko, и др.
Опубликовано: (2023-12-01)

Cancer mortality distribution in South Africa, 1997–2016
по: Mandlakayise Lucky Nhleko, и др.
Опубликовано: (2023-06-01)

Costs of the COVID-19 vaccination programme: estimates from the West Rand district of South Africa, 2021/2022
по: Ijeoma Edoka, и др.
Опубликовано: (2024-07-01)

Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients
по: Kaiyan Liu, и др.
Опубликовано: (2023-03-01)

UPLC-PDA factorial design assisted method for simultaneous determination of oseltamivir, dexamethasone, and remdesivir in human plasma
по: Hanan I. EL-Shorbagy, и др.
Опубликовано: (2024-09-01)

Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan
по: Yi-Hsuan Lai, и др.
Опубликовано: (2023-12-01)

Integrated multi‐month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost‐effectiveness
по: Youngji Jo, и др.
Опубликовано: (2025-02-01)

Cost and outcomes of routine HIV care and treatment: public and private service delivery models covering low-income earners in South Africa
по: L. C. Long, и др.
Опубликовано: (2023-03-01)

Modelling the Cost-Effectiveness of Hepatitis A in South Africa
по: Jenna Patterson, и др.
Опубликовано: (2024-01-01)

Death trends for 2010 - 2022 for members of a large private medical scheme in South Africa
по: L Steenkamp, и др.
Опубликовано: (2024-07-01)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data
по: Mariet Benade, и др.
Опубликовано: (2022-01-01)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data.
по: Mariet Benade, и др.
Опубликовано: (2022-01-01)

Simultaneous HPLC determination of remdesivir and dexamethasone in the presence of metformin, sitagliptin, and glimepiride in a synthetic mixture and spiked human plasma
по: Stanislav Bozhanov, и др.
Опубликовано: (2024-03-01)

Healthcare costs of paternal depression in the postnatal period.
по: Edoka, I, и др.
Опубликовано: (2011)

Healthcare costs of paternal depression in the postnatal period
по: Edoka, I, и др.
Опубликовано: (2011)

Towards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modelling approach.
по: Silal, S, и др.
Опубликовано: (2014)

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review
по: Sithabiso D. Masuku, и др.
Опубликовано: (2022-12-01)

Attrition through multiple stages of pre-treatment and ART HIV care in South Africa.
по: Matthew P Fox, и др.
Опубликовано: (2014-01-01)

Clinical outcomes of remdesivir-treated COVID-19 patients in South Korea
по: Mi Yu, и др.
Опубликовано: (2022-10-01)

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
по: Calvin Chiu, и др.
Опубликовано: (2017-01-01)

Exploring the seasonality of reported treated malaria cases in Mpumalanga, South Africa.
по: Sheetal Prakash Silal, и др.
Опубликовано: (2013-01-01)

The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa.
по: Lawrence C Long, и др.
Опубликовано: (2016-01-01)

Xpert MTB/XDR implementation in South Africa: cost outcomes of centralised vs. decentralised approaches
по: N. Cassim, и др.
Опубликовано: (2024-05-01)

Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves.
по: Jeremy Bingham, и др.
Опубликовано: (2023-01-01)

Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation.
по: Gennaro De Pascale, и др.
Опубликовано: (2022-01-01)

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
по: Aziz Rezapour, и др.
Опубликовано: (2023-04-01)